Recombinant Varicella Zoster Virus Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Varicella Zoster Virus Vaccine, covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population [Phase 1, Phase 2]